Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Landmark green light for Mosquirix malaria vaccine.

Literature DB >> 26448075

Landmark green light for Mosquirix malaria vaccine.

Chris Morrison.

Abstract

Entities: Disease

Mesh：

Substances：
Malaria Vaccines

Year: 2015 PMID： 26448075 DOI： 10.1038/nbt1015-1015

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

3 in total

1. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

Authors:
Journal: Lancet Date: 2015-04-23 Impact factor: 79.321

2. Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.

Authors: Susanne H Hodgson; Katie J Ewer; Carly M Bliss; Nick J Edwards; Thomas Rampling; Nicholas A Anagnostou; Eoghan de Barra; Tom Havelock; Georgina Bowyer; Ian D Poulton; Simone de Cassan; Rhea Longley; Joseph J Illingworth; Alexander D Douglas; Pooja B Mange; Katharine A Collins; Rachel Roberts; Stephen Gerry; Eleanor Berrie; Sarah Moyle; Stefano Colloca; Riccardo Cortese; Robert E Sinden; Sarah C Gilbert; Philip Bejon; Alison M Lawrie; Alfredo Nicosia; Saul N Faust; Adrian V S Hill
Journal: J Infect Dis Date: 2014-10-21 Impact factor: 5.226

3. Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.

Authors: Christian F Ockenhouse; Jason Regules; Donna Tosh; Jessica Cowden; April Kathcart; James Cummings; Kristopher Paolino; James Moon; Jack Komisar; Edwin Kamau; Thomas Oliver; Austin Chhoeu; Jitta Murphy; Kirsten Lyke; Matthew Laurens; Ashley Birkett; Cynthia Lee; Rich Weltzin; Ulrike Wille-Reece; Martha Sedegah; Jenny Hendriks; Isabella Versteege; Maria Grazia Pau; Jerold Sadoff; Yannick Vanloubbeeck; Marc Lievens; Dirk Heerwegh; Philippe Moris; Yolanda Guerra Mendoza; Erik Jongert; Joe Cohen; Gerald Voss; W Ripley Ballou; Johan Vekemans
Journal: PLoS One Date: 2015-07-06 Impact factor: 3.240

3 in total

22 in total

Landmark green light for Mosquirix malaria vaccine.

1. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

2. Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.

3. Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.

Review 1. Phenotypic Screens in Antimalarial Drug Discovery.

2. Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell Responses.

Review 3. Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development.

Review 4. Adjuvants: tailoring humoral immune responses.

Review 5. Development of a schistosomiasis vaccine.

Review 6. Vaccinations for Neuroinfectious Disease: A Global Health Priority.

Review 7. Correlates of GLA family adjuvants' activities.

Review 8. Increasing efficiency in vaccine Production: A primer for change.

9. Development & licensing of first ever vaccine against malaria.

Review 10. Progress and prospects for blood-stage malaria vaccines.